Difference between revisions of "Alinidine"
From Self-sufficiency
m (Adding category Category:Alkenes (using HotCat)) |
m (1 revision) |
||
| (One intermediate revision by one other user not shown) | |||
| Line 21: | Line 21: | ||
'''Alinidine''' ('''ST567''') is a negative [[chronotrope]] that was developed in the 70's and 80's. It causes [[bradycardia]] by inhibiting the pacemaker current by altering the maximal channel conductance and alter the voltage threshold.<ref>Snyders DJ, Van Bogaert P-P: Alinidine modifies the pacemaker current in sheep Purkinje fibers. Pflugers Arch 1987, 410:83-91</ref> The development of alinidine was halted because it was not sufficiently specific for its target. It also has a blocking effect on [[Calcium channel|calcium channels]] and [[Potassium channel|potassium channels]]. It also causes elongation of re-polarisation after an [[action potential]].<ref>Current Opinion in Pharmacology 2007, 7:208–213</ref> | '''Alinidine''' ('''ST567''') is a negative [[chronotrope]] that was developed in the 70's and 80's. It causes [[bradycardia]] by inhibiting the pacemaker current by altering the maximal channel conductance and alter the voltage threshold.<ref>Snyders DJ, Van Bogaert P-P: Alinidine modifies the pacemaker current in sheep Purkinje fibers. Pflugers Arch 1987, 410:83-91</ref> The development of alinidine was halted because it was not sufficiently specific for its target. It also has a blocking effect on [[Calcium channel|calcium channels]] and [[Potassium channel|potassium channels]]. It also causes elongation of re-polarisation after an [[action potential]].<ref>Current Opinion in Pharmacology 2007, 7:208–213</ref> | ||
| − | Alinidine did not improve outcomes among patients with acute [[myocardial infarction]] in a [[randomized controlled trial]].<ref name="pmid8335810">{{cite journal| author=Van de Werf F, Janssens L, Brzostek T, Mortelmans L, Wackers FJ, Willems GM et al.| title=Short-term effects of early intravenous treatment with a beta-adrenergic blocking agent or a specific bradycardiac agent in patients with acute myocardial infarction receiving thrombolytic therapy. | journal=J Am Coll Cardiol | year= 1993 | volume= 22 | issue= 2 | pages= | + | Alinidine did not improve outcomes among patients with acute [[myocardial infarction]] in a [[randomized controlled trial]].<ref name="pmid8335810">{{cite journal| author=Van de Werf F, Janssens L, Brzostek T, Mortelmans L, Wackers FJ, Willems GM et al.| title=Short-term effects of early intravenous treatment with a beta-adrenergic blocking agent or a specific bradycardiac agent in patients with acute myocardial infarction receiving thrombolytic therapy. | journal=J Am Coll Cardiol | year= 1993 | volume= 22 | issue= 2 | pages= 407–16 | pmid=8335810 |
| url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=clinical.uthscsa.edu/cite&retmode=ref&cmd=prlinks&id=8335810 }}</ref> | | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=clinical.uthscsa.edu/cite&retmode=ref&cmd=prlinks&id=8335810 }}</ref> | ||
Latest revision as of 21:29, 21 September 2010
| File:Alinidine.png | |
| Systematic (IUPAC) name | |
|---|---|
|
N-(2,6-dichlorophenyl)-N-(prop-2-en-1-yl)-4,5-dihydro-1H-imidazol-2-amine | |
| Legal status | |
| Legal status |
|
| Identifiers | |
| CAS Number | 33178-86-8 |
| ATC code | none |
| PubChem | CID 36354 |
| ChemSpider | 33429 |
| Chemical data | |
| Formula | C12H13Cl2N3 |
| Molar mass | 270.16 g/mol[[Script error: No such module "String".]] |
| Script error: No such module "collapsible list". | |
Alinidine (ST567) is a negative chronotrope that was developed in the 70's and 80's. It causes bradycardia by inhibiting the pacemaker current by altering the maximal channel conductance and alter the voltage threshold.[1] The development of alinidine was halted because it was not sufficiently specific for its target. It also has a blocking effect on calcium channels and potassium channels. It also causes elongation of re-polarisation after an action potential.[2]
Alinidine did not improve outcomes among patients with acute myocardial infarction in a randomized controlled trial.[3]
References
Cite error: Invalid <references> tag;
parameter "group" is allowed only.
<references />, or <references group="..." />
- ↑ Snyders DJ, Van Bogaert P-P: Alinidine modifies the pacemaker current in sheep Purkinje fibers. Pflugers Arch 1987, 410:83-91
- ↑ Current Opinion in Pharmacology 2007, 7:208–213
- ↑ Van de Werf F, Janssens L, Brzostek T, Mortelmans L, Wackers FJ, Willems GM; et al. (1993). "Short-term effects of early intravenous treatment with a beta-adrenergic blocking agent or a specific bradycardiac agent in patients with acute myocardial infarction receiving thrombolytic therapy". J Am Coll Cardiol. 22 (2): 407–16. PMID 8335810.
Categories:
- Pages with script errors
- Pages with broken file links
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs not assigned an ATC code
- Articles containing unverified chemical infoboxes
- 2Fix
- Cardiovascular system
- Antiarrhythmic agents
- Organochlorides
- Aromatic amines
- Imidazolines
- Alkenes
- CS1 maint: Explicit use of et al.
- CS1 maint: Multiple names: authors list
